Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
The global conversation around obesity and type 2 diabetes management has shifted dramatically in recent years, largely due to the rise of GLP-1 receptor compounds. Among them, semaglutide has emerged…
Novo Nordisk now wants Sun Pharma to stop dealing in weight loss drug compound, goes to Delhi HC again
Danish pharma giant says in process of challenging earlier verdict, where court allowed Dr Reddy’s to make and export weight-loss drug Danish pharma giant Novo Nordisk has moved the Delhi…
